Compare BLNK & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLNK | ARAY |
|---|---|---|
| Founded | 2009 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.2M | 100.5M |
| IPO Year | N/A | 2007 |
| Metric | BLNK | ARAY |
|---|---|---|
| Price | $0.70 | $0.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $2.13 | ★ $3.50 |
| AVG Volume (30 Days) | ★ 3.4M | 839.3K |
| Earning Date | 03-12-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $106,631,000.00 | ★ $436,969,000.00 |
| Revenue This Year | N/A | $3.82 |
| Revenue Next Year | $17.87 | $4.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.63 | $0.54 |
| 52 Week High | $2.65 | $2.95 |
| Indicator | BLNK | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 39.95 | 21.72 |
| Support Level | $0.64 | $0.54 |
| Resistance Level | $0.72 | $0.83 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 21.10 | 14.03 |
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.